Although all valuations are speculative in nature,I believe Col’s is far more plausible than ValueAdd’s. $2/share is way under value in any way the pie is cut.
What if CF33 as a monotherapy outperforms the combination treatments? What if the OV completely disrupts existing treatments altogether? What if it is used as a vaccine? How long can the OV remain viable in the body? Could ppl require an annual / regular vaccine? How will potential combo treatments be split? 50/50, 80/20? The possibilities are vast. If CF33 reaches the heights we are all hoping, every government across the globe will want a piece of it. It will change humanity. Productivity, healthcare costs, quality of life, quality of relationships, no side effects.. the implications are mind-boggling.
In my eyes this company could well be a 100-bagger. I will not be selling at $2/share
IMU Target $2.00 - Not Ramping !!!, page-6
-
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $1.098M | 21.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 97 | 7481668 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 1703097 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |